Orion Industries logo

Emcure Pharma IPO Reservation

03 July - 05 July 2024 Closed
Mainboard BSE,NSE

The Emcure Pharma IPO reservation is divided among different investor categories in accordance with SEBI regulations and the company's offer structure. A total of 1,94,83,388 equity shares are available for allocation across Qualified Institutional Buyers (QIBs), Non-Institutional Investors (NIIs), Retail Individual Investors (RIIs), and Employees.

The Retail Individual Investor (RII) category has the highest allocation with 67,43,160 shares, representing 34.61% of the total issue. Qualified Institutional Buyers (QIBs) are allocated 38,53,234 shares (19.78%), while Non-Institutional Investors (NIIs) receive 28,89,926 shares (14.83%). The NII portion is further divided into Big Non-Institutional Investors (BNII) with 19,26,618 shares (9.89%) and Small Non-Institutional Investors (SNII) with 9,63,309 shares (4.94%).

The IPO also includes a dedicated reservation for Employees, comprising 1,08,900 shares (0.56%). This category-wise reservation provides a clear view of how the IPO shares are distributed among eligible investor groups.

*Info is indicative. Not an Investment Advice. Grey market trading is unregulated.

IPO Reservations

Category Shares Offered Shares Offered % Max Allotee
Anchor Investors577985029.670
Qualified Institutions385323419.780
Non-Institutional288992614.830
BNII19266189.899174
SNII9633094.944587
Retail Investors674316034.61481654
Employees1089000.560
Total194833881000

Disclaimer: This data is for informational purposes only and does not constitute investment advice. Figures shown are illustrative sample data.

Frequently Asked Questions

Everything you need to know before applying to an IPO.

What is the retail investor quota in the Emcure Pharma IPO?

The Retail Individual Investor (RII) quota in the Emcure Pharma IPO comprises 67,43,160 equity shares, representing 34.61% of the total IPO issue.

What is the reservation for QIBs in the Emcure Pharma IPO?

Qualified Institutional Buyers (QIBs) have been allocated 38,53,234 equity shares, representing 19.78% of the total IPO issue.

What is the reservation for HNI investors in the Emcure Pharma IPO?

The Non-Institutional Investors (NII) category has been allotted 28,89,926 equity shares (14.83%). This category is further divided into: Big HNI (bNII): 9,63,309 shares (9.89%) Small HNI (sNII): 19,26,618 shares (4.94%).

What is the category-wise reservation in the Emcure Pharma IPO?

The Emcure Pharma IPO reservation is divided as follows: Qualified Institutional Buyers (QIB): 38,53,234 shares (19.78%). Non-Institutional Investors (NII): 28,89,926 shares (14.83%). Retail Individual Investors (RII): 67,43,160 shares (34.61%). Employees: 1,08,900 shares (0.56%).

Is there an employee reservation in the Emcure Pharma IPO?

Yes. The Emcure Pharma IPO has reserved 1,08,900 equity shares, representing 0.56% of the total issue for eligible employees.

Is there a shareholder quota in the Emcure Pharma IPO?

No. The Emcure Pharma IPO does not include a shareholder reservation.